375.25
-1.34%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dabur India
Its shares trade on NSE under the ticker DABUR.NS. It has been listed since 8 June 1905. In the fiscal year to 31 March 2026, it reported revenue of ₹131.93bn and net income of ₹18.95bn. At that date it held total assets of ₹174.80bn and shareholders' equity of ₹114.20bn.
Dabur India Ltd. engages in the distribution of fast moving consumer goods. The company is headquartered in Ghaziabad, Uttar Pradesh. Its segments include Consumer care business, Food business, Retail business and Other segments. Its Consumer care business segment includes home care, personal care, and health care. Its Food business segment includes juices, beverages, and culinary. Its Retail business segment includes retail stores. Its Other segments include Guar gum, pharma and others. Its product categories include hair care, oral care, health care, skin care, home care and foods. Its FMCG portfolio includes eight brands, including Dabur Chyawanprash, Dabur Honey, Dabur PudinHara, Dabur Lal Tail and Dabur Honitus in the healthcare space; Dabur Amla and Dabur Red Paste in the personal care category; and Real in the food and Beverage’s category. In addition, Vatika is an international brand. Its products include Real Juices, Dabur Red Paste, Odonil, Odomos, Dabur Hommade Tasty Masala, Rheumatil Oil, Dabur Badam Oil, Odopic, Oxy bleach and Hajmola.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 8 Jun 1905
- Employees
- 8,562
- Website
- dabur.com ↗
Leadership
Pay as last reported
- Mr. Mohit BurmanNon-Executive Chairman of the Board₹60,000
- Mr. Mohit MalhotraChief Executive Officer, Whole Time Director, since 2019₹146.4m
- Mr. Saket BurmanNon-Executive Vice Chairman of the Board₹60,000
- Mr. Ankush JainChief Financial Officer, Joint Chief Risk Officer
- Mr. Ashok JainExecutive Vice President - Finance, Group Company Secretary, since 2024₹12.5m
- Mr. Saket GuptaChief Compliance Officer, Joint Company Secretary
- Mr. Saurabhkumar LalExecutive Director - Operations, since 2024
- Mr. Pritam NarangGroup Director - Corporate Affairs, Whole-Time Director₹162.5m
- Mr. Abhinav DhallExecutive Director - Group Corporate Strategy
- Mr. Mukesh ButaniLead Non-Executive Independent Director₹1.0m
- Mr. Aditya BurmanNon-Executive Director
- Mr. Amit BurmanNon-Executive Director, since 2001₹120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 83
- Environment
- 83
- Social
- 76
- Governance
- 90
- Direct emissions (scope 1)
- 12,185 t
- Energy emissions (scope 2)
- 49,644 t
- Value chain emissions (scope 3)
- 522,766 t
- Women in the workforce
- 5.14254%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dabur India Ltd has a strong brand reputation in the Indian market, known for its high-quality Ayurvedic products.
- The company has a wide distribution network, ensuring its products are easily accessible to customers across the country.
- Dabur India Ltd has a diversified product portfolio, including healthcare, personal care, and food products.
Weaknesses
- One of the weaknesses of Dabur India Ltd is its dependence on the Indian market, leaving it vulnerable to economic fluctuations and regulatory changes within the country.
- The company may face challenges in expanding internationally and competing against established global players in the Ayurvedic market.
- Dabur India Ltd relies heavily on traditional distribution channels, which may limit its ability to adapt to changing consumer preferences towards e-commerce.
Opportunities
- There is a growing demand for natural and herbal products, presenting an opportunity for Dabur India Ltd to expand its customer base and introduce innovative offerings.
- The increasing health consciousness among consumers opens avenues for Dabur India Ltd to promote its Ayurvedic healthcare and wellness products.
- The company can explore strategic partnerships or acquisitions to enter new international markets or diversify its product range.
Threats
- The presence of counterfeit Ayurvedic products in the market poses a threat to the reputation and market share of Dabur India Ltd.
- Intense competition from both domestic and international players in the Ayurvedic and FMCG sectors can impact the market position of Dabur India Ltd.
- Changes in government regulations regarding the use of certain ingredients or manufacturing practices may affect the company's product formulations and operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.